Cervical Cancer Screening Cascade in Côte d’Ivoire: A Decade of Real-World Program Evaluation According to HIV Status
Authors:
- Simon BoniSBSimon Boni
- Mesmin AdieMAMesmin Adie
- Franck GnahatinFGFranck Gnahatin
- Denise KpeboDKDenise Kpebo
- Apollinaire HoroAHApollinaire Horo
- Antoine JaquetAJAntoine Jaquet
- on behalf The IeDEA West Africa CollaborationOCon behalf The IeDEA West Africa Collaboration
Open Access
- 1 April 2026
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (4) , e2500164
Abstract
PURPOSE: We assessed progress toward WHO 2030 Cervical Cancer (CC) elimination targets including 70% coverage for CC screening and 90% of precancerous lesions treated according to HIV status in Côte d’Ivoire during the 2010-2021 period. METHODS: A national CC screening registry was initiated in Côte d’Ivoire since 2010, collecting individual-level data from all health facilities offering visual inspection with acetic acid (VIA). The CC screening coverage was estimated based on the 2021 population census and the HIV national database in women aged 25-49 years from the general population and in women with HIV (WLHIV). CC screening and care cascade indicators were documented over time and compared according to HIV status. Access to same-day cryotherapy and associated factors were analyzed through a logistic regression model. RESULTS: A total of 66,268 women received CC screening, with 11,251 (17.0%) being WLHIV. The estimated CC screening coverage was 4.4% (2.6-5.2), rising to 13.9% (13.5-15.3) in WLHIV. Overall, VIA positivity was 6.4% (6.2-6.5) and was higher in WLHIV (9.1% [8.6-9.7]), P < .001. Among VIA-positive women, 3,500 (83.1%) were eligible for same-day cryotherapy. Access to cryotherapy was 59.1%, declining over time from 71.7% before 2015 to 51.9% in 2021. Access to cryotherapy was higher in WLHIV (aOR, 1.55 [95% CI, 1.32 to 1.84]) and women screened in secondary-level (aOR, 1.82 [95% CI, 1.49 to 2.23]) or tertiary-level facilities (aOR, 1.79 [95% CI, 1.54 to 2.09]) versus primary level. CONCLUSION: Despite major achievements in this 11-year implementation of the CC screening program in Côte d’Ivoire, performances remained low regardless of HIV status and far from elimination targets in 2021. These findings underline the need to endorse new screening strategies based on HPV testing and thermal ablation treatment at a national level.Keywords
This publication has 24 references indexed in Scilit:
- Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohortsJournal of the International AIDS Society, 2024
- Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021The Lancet HIV, 2024
- Cervical cancer prevention and care in HIV clinics across sub‐Saharan Africa: results of a facility‐based surveyJournal of the International AIDS Society, 2024
- Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV CohortsOpen Forum Infectious Diseases, 2024
- Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysisThe Lancet Global Health, 2022
- Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysisPublic Health, 2021
- Estimates of the global burden of cervical cancer associated with HIVThe Lancet Global Health, 2021
- Assessment of the scale‐up of cervical cancer screening in Abidjan stratified by HIV statusInternational Journal of Gynecology & Obstetrics, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009